{
    "2018-11-14": [
        [
            {
                "time": "2018-01-02",
                "original_text": "AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study",
                "features": {
                    "keywords": [
                        "Mavyret",
                        "HCV",
                        "label expansion",
                        "success"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Migraine-Focused Biotech Has A Headache On Quarterly Losses",
                "features": {
                    "keywords": [
                        "migraine",
                        "biotech",
                        "quarterly losses",
                        "headache"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study",
                "features": {
                    "keywords": [
                        "Mavyret",
                        "HCV",
                        "label expansion",
                        "success"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Merck Starts Rolling BLA Submission for Ebola Vaccine V920",
                "features": {
                    "keywords": [
                        "Merck",
                        "BLA submission",
                        "Ebola vaccine",
                        "V920"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Shire's Filing Accepted by FDA for Gattex's Label Expansion",
                "features": {
                    "keywords": [
                        "Shire",
                        "FDA",
                        "Gattex",
                        "label expansion",
                        "filing accepted"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Shire's Filing Accepted by FDA for Gattex's Label Expansion",
                "features": {
                    "keywords": [
                        "Shire",
                        "FDA",
                        "Gattex",
                        "label expansion",
                        "filing accepted"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Eli Lilly announces progress on new headache medications",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "headache medications",
                        "progress"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgalityâ„¢ (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache",
                "features": {
                    "keywords": [
                        "Lilly",
                        "FDA",
                        "Lasmiditan",
                        "Emgality",
                        "breakthrough therapy",
                        "migraine",
                        "cluster headache"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}